Reprint
The Role of PPARs in Disease
Edited by
April 2022
274 pages
- ISBN978-3-0365-3992-8 (Hardback)
- ISBN978-3-0365-3991-1 (PDF)
This book is a reprint of the Special Issue The Role of PPARs in Disease that was published in
Biology & Life Sciences
Medicine & Pharmacology
Summary
This reprint combines recent original manuscripts and reviews covering the multiple functions of peroxisome proliferator-activated receptors in physiology and pathophysiology. Potential applications and limitations of PPAR agonists and antagonists are discussed. All original contributions were published in Cells.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
peroxisome-proliferator activated receptors; tumor angiogenesis; tumor progression; metastasis formation; endothelial cells; RNA sequencing; PPARs; toxicology; pharmacology; ligand; PPARs; vascular; coronary artery; lipidomics; eicosanoids; inflammation; CYP450; peroxisome proliferator-activated receptor; angiogenesis; proliferation; metastasis; immortality; resistance to cell death; growth suppressors; immune system; cellular metabolism; PPAR; nuclear receptors; addiction; alcohol; nicotine; opioids; psychostimulants; animal models; human studies; Alzheimer’s; risk factors; PPARs; PPARα; lipids; fatty acids; modulators; cognition; sex; therapy; hypertrophic adipocytes; PPARG isoforms; PPARG splicing; dominant-negative isoform; in vitro adipocytes; adipogenesis; hypertrophic obesity; insulin-resistance; peroxisome proliferator-activated receptors (PPARs); synthetic agonists; non-alcoholic fatty liver disease (NAFLD); non-alcoholic steatohepatitis (NASH); fibrosis; Sirtuin1; peroxisome proliferator-activated receptor-γ coactivator-1α; peroxisome proliferator activated receptors; obesity; metabolic syndrome; vitamin B12; folate; fetal programming; inherited metabolic disorders; PGC-1α, disease; kidney; cancer; AKI; CKD; nephron; PKD; cilia; cystogenesis; peroxisome proliferator-activated receptors (PPARs); toxicology; pharmacology; ligands; vascular; proliferation; cellular metabolism; adipogenesis; hypertrophic obesity; insulin-resistance; lipidomics; inflammation; kidney; cancer; tumor angiogenesis; peroxisome proliferator-activated receptor-γ coactivator-1α; non-alcoholic fatty liver disease (NAFLD); non-alcoholic steatohepatitis (NASH); fibrosis; Alzheimer’s disease (AD); addiction; alcohol; nicotine; opioids; psychostimulants; animal models; human studies